Last checked at 29 Jan 2021 13:31
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 28 January 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) | Relevant securities |
|
|
|
|
2,383,173 | 1.85% | 605,666 | 0.47% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
273,127 | 0.21% | 445,393 | 0.35% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 6,000 | 0.00% | 6,000 | 0.00% | |
|
|
|
| ||
(4) | TOTAL: |
|
|
|
|
2,662,300 | 2.07% | 1,057,059 | 0.82% | ||
|
|
|
| ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 1 | 209.3000 USD |
Purchase | 38 | 207.5094 USD |
Purchase | 40 | 207.2788 USD |
Purchase | 42 | 207.4385 USD |
Purchase | 50 | 208.6900 USD |
Purchase | 66 | 207.2590 USD |
Purchase | 69 | 207.2191 USD |
Purchase | 71 | 208.0553 USD |
Purchase | 75 | 207.4040 USD |
Purchase | 82 | 207.4714 USD |
Purchase | 90 | 207.1970 USD |
Purchase | 96 | 207.3006 USD |
Purchase | 100 | 206.1900 USD |
Purchase | 100 | 206.2000 USD |
Purchase | 100 | 206.9800 USD |
Purchase | 100 | 207.2000 USD |
Purchase | 100 | 207.2500 USD |
Purchase | 100 | 208.3400 USD |
Purchase | 100 | 208.4700 USD |
Purchase | 100 | 208.5000 USD |
Purchase | 100 | 208.5700 USD |
Purchase | 100 | 208.7750 USD |
Purchase | 100 | 208.7900 USD |
Purchase | 102 | 207.7994 USD |
Purchase | 118 | 207.2400 USD |
Purchase | 185 | 207.2700 USD |
Purchase | 200 | 206.2650 USD |
Purchase | 200 | 207.6900 USD |
Purchase | 205 | 206.3606 USD |
Purchase | 211 | 207.4905 USD |
Purchase | 268 | 207.3104 USD |
Purchase | 284 | 208.5630 USD |
Purchase | 383 | 208.2479 USD |
Purchase | 393 | 207.3125 USD |
Purchase | 808 | 207.2344 USD |
Purchase | 834 | 208.5514 USD |
Purchase | 959 | 207.0706 USD |
Purchase | 1,058 | 207.6593 USD |
Purchase | 1,123 | 207.6912 USD |
Purchase | 1,255 | 207.0778 USD |
Purchase | 1,621 | 206.7608 USD |
Purchase | 3,758 | 206.3100 USD |
Purchase | 3,804 | 206.3543 USD |
Purchase | 6,209 | 207.0068 USD |
Purchase | 6,999 | 207.1052 USD |
Sale | 2 | 206.0900 USD |
Sale | 2 | 208.5500 USD |
Sale | 7 | 207.3200 USD |
Sale | 10 | 207.3480 USD |
Sale | 33 | 207.2700 USD |
Sale | 100 | 206.2100 USD |
Sale | 100 | 207.4800 USD |
Sale | 174 | 206.4611 USD |
Sale | 183 | 208.1582 USD |
Sale | 200 | 207.6900 USD |
Sale | 206 | 207.6486 USD |
Sale | 218 | 208.2400 USD |
Sale | 219 | 207.3330 USD |
Sale | 250 | 207.2279 USD |
Sale | 665 | 206.3144 USD |
Sale | 834 | 208.5514 USD |
Sale | 834 | 208.5515 USD |
Sale | 917 | 207.7008 USD |
Sale | 948 | 207.3252 USD |
Sale | 1,008 | 207.2615 USD |
Sale | 1,123 | 207.6912 USD |
Sale | 1,262 | 207.0822 USD |
Sale | 1,355 | 207.0130 USD |
Sale | 2,985 | 206.3100 USD |
Sale | 3,315 | 206.3129 USD |
Sale | 7,204 | 206.9617 USD |
Sale | 8,139 | 207.1045 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | YES |
| Date of disclosure: | 29 Jan 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
| Product name | Written or | Number of | Exercise | Type | Expiry |
| purchased | relevant securities | price | date | ||
| to which the option | |||||
| or derivative | |||||
| relates | |||||
Call Options | Purchased | 6,000 | 220.0000 | American | Jul 16, 2021 |
Put Options | Purchased | -6,000 | 200.0000 | American | Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210129005322/en/
Copyright Business Wire 2021